Lawrence Waldman
Known title: DirectorCIK: 0001516592
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Yahoo compares Hurco and CVD Equipment in recent article. Yahoo published a piece that compares Hurco and CVD Equipment, looking at their industrial equipment businesses and financial metrics. The article highlights CVD's low trailing P/E and its position near the lower end of its 52‑week range. This comparison may draw attention to CVD's valuation and recent price weakness. Investors may note the discussion as part of broader sector analysis.
Transaction History
| APYX | ▲ Buy | Option Exercise | 12,000 | $23K | 6/30/2026 | View on chart |
| APYX | ▼ Sell | Tax Withholding | 5,024 | $23K | 6/30/2026 | View on chart |
| CVV | ▲ Buy | Grant | 11,100 | $0 | 8/8/2025 | View on chart |
| CVV | ▲ Buy | Grant | 11,300 | $0 | 8/9/2024 | View on chart |
| CVV | ▲ Buy | Grant | 2,915 | $0 | 7/13/2023 | View on chart |
| CVV | ▲ Buy | Grant | 5,831 | $0 | 7/13/2023 | View on chart |
| APYX | ▲ Buy | Option Exercise | 5,338 | $16K | 7/12/2023 | View on chart |
| CVV | ▲ Buy | Grant | 8,000 | $40K | 8/17/2022 | View on chart |
| APYX | ▲ Buy | Option Exercise | 24,000 | $61K | 7/11/2022 | View on chart |
| APYX | ▲ Buy | Option Exercise | 8,000 | $22K | 5/19/2022 | View on chart |
| CVV | ▲ Buy | Grant | 9,600 | $45K | 1/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Apyx Medical featured in cold plasma market growth report
Apyx Medical was named as a key player in a new report projecting the cold plasma market to grow from $3.32 billion in 2025 to $8.45 billion by 2032. This industry-level forecast highlights the long-term potential of the sector in which Apyx operates. The company's stock is currently trading below its average analyst target price, reflecting ongoing market uncertainty despite these broader industry trends.
Apyx Medical featured in cold plasma market growth report. Apyx Medical was named as a key player in a new report projecting the cold plasma market to grow from $3.32 billion in 2025 to $8.45 billion by 2032. This industry-level forecast highlights the long-term potential of the sector in which Apyx operates. The company's stock is currently trading below its average analyst target price, reflecting ongoing market uncertainty despite these broader industry trends.